Ip C - Search Results

1

Selenium compounds regulate p53 by common and distinctive mechanisms.

Smith ML, Lancia JK, Mercer TI, Ip C. Smith ML, et al. Among authors: ip c. Anticancer Res. 2004 May-Jun;24(3a):1401-8. Anticancer Res. 2004. PMID: 15274301

2

Chemoprevention with triphenylselenonium chloride in selenium-deficient rats.

Ip C, Lisk DJ, Ganther HE. Ip C, et al. Anticancer Res. 2000 Nov-Dec;20(6B):4179-82. Anticancer Res. 2000. PMID: 11205245

3

Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents.

Ip C, Lisk DJ, Ganther HE. Ip C, et al. Anticancer Res. 1998 Nov-Dec;18(6A):4019-25. Anticancer Res. 1998. PMID: 9891440

4

Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile.

Ip C, Lisk DJ, Ganther H, Thompson HJ. Ip C, et al. Anticancer Res. 1997 Sep-Oct;17(5A):3195-9. Anticancer Res. 1997. PMID: 9413148

5

Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.

Cho SD, Jiang C, Malewicz B, Dong Y, Young CY, Kang KS, Lee YS, Ip C, Lü J. Cho SD, et al. Among authors: ip c. Mol Cancer Ther. 2004 May;3(5):605-11. Mol Cancer Ther. 2004. PMID: 15141018

6

Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.

Li S, Zhou Y, Dong Y, Ip C. Li S, et al. Among authors: ip c. Anticancer Res. 2007 Sep-Oct;27(5A):3075-82. Anticancer Res. 2007. PMID: 17970047

7

Endoplasmic reticulum stress signal mediators are targets of selenium action.

Wu Y, Zhang H, Dong Y, Park YM, Ip C. Wu Y, et al. Among authors: ip c. Cancer Res. 2005 Oct 1;65(19):9073-9. doi: 10.1158/0008-5472.CAN-05-2016. Cancer Res. 2005. PMID: 16204082

8

Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.

Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC. Lee SO, et al. Among authors: ip c. Cancer Res. 2005 Apr 15;65(8):3487-92. doi: 10.1158/0008-5472.CAN-04-3267. Cancer Res. 2005. PMID: 15833885

9

Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention.

Wu Y, Zu K, Ni J, Yeh S, Kasi D, James NS, Chemler S, Ip C. Wu Y, et al. Among authors: ip c. Anticancer Res. 2004 Nov-Dec;24(6):3795-802. Anticancer Res. 2004. PMID: 15736414

10

Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells.

Zu K, Ip C. Zu K, et al. Among authors: ip c. Cancer Res. 2003 Oct 15;63(20):6988-95. Cancer Res. 2003. PMID: 14583501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results